Profile

    Corporate information

    Official name
    Visum Therapeutics Incorporated

    Registration country
    Investment activity status
    Active investor

    Company type

    Provider of a small molecule therapeutic to treat Stargardt's disease, a degenerative condition that leads to blindness.

    Funding rounds


    Profile Country Notes
    BioEnterprise United States

    Current and past shareholders

    Investor Round
    BioEnterprise logo BioEnterprise
    N/A